Scleromyxedema: Successful treatment of cutaneous and neurologic symptoms

Cutis

Volumn 65, Issue 2, 2000, Pages 89-92

  Nieves, David S ^a   Bondi, Edward E ^a,c   Wallmark, John ^b   Raps, Eric C ^a   Seykora, John T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Associates in Oncol and Hematology   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; LICHENOID ERUPTION; MALE; MIDDLE AGED; MYXEDEMA; SYSTEMIC SCLEROSIS;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; LICHENOID ERUPTIONS; MALE; MIDDLE AGED; MYXEDEMA; SCLERODERMA, SYSTEMIC;

EID: 0034134096     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dubreuilh W: Fibromes miliares folliculaires: sclerodermie consecutive. Ann Dermatol Syph 37: 569-572, 1906.
2. Montgomery H, Underwood LJ: Lichen myxedematosus (differentiation from cutaneous myxedemas or mucoid states). J Invest Dermatol 20: 213-216, 1953.
3. McAdam LP, Pearson CM, Pitts WH, et al.: Papular mucinosis with myopathy, arthritis and eosinophilia: a histopathologic study. Arthritis Rheum 20: 989-996, 1977.
4. Verity MA, Toop J, McAdam LP, et al.: Scleromyxedema myopathy: histochemical and electron microscopic observations. Am J Clin Pathol 69: 446-451, 1978.
5. Braverman IM: Skin Signs of Systemic Disease, 2nd ed, p 233. Philadelphia, Saunders, 1981.
6. Alligood TR, Burnett JW, Raines BL: Scleromyxedema associated with esophageal aperistalsis and dermal eosinophilia. Cutis 28: 60-63, 1981.
7. Gabriel SE, Perry HO, Oleson GB, et al.: Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine 37: 58-65, 1988.
8. McCuiston SH, Schoch EP: Autopsy findings in lichen myxedematosus. Arch Dermatol 74: 259-262, 1956.
9. Donald GF, Hensley WJ, McGovern VJ: Lichen myxedematosus (papular mucinosis): a brief review of the literature and report of a case which failed to respond to ACTH and cortisone. Aus J Dermatol 2: 28-34, 1953.
10. Findley GH, Simson IW: Scleromyxoedema. S Afr Med J 23: 69-71, 1960.
11. Perry HO, Montgomery H, Stickney JM: Further observations on lichen myxedematosus. Ann Intern Med 53: 955-969, 1960.
12. Rudner EJ, Mehregan A, Pinkus H: Scleromyxedema: a variant of lichen myxedematosus. Arch Dermatol 93: 3-12, 1966.
13. Lai a Fat RF, Suurmond D, Radl J, et al.: Scleromyxedema (lichen myxoedematosus) associated with a paraprotein, IgG, of type kappa. Br J Dermatol 88: 107-116, 1973.
14. Ochtill HN, Amberson J: Acute cerebral symptomatology, a rare presentation of scleromyxedema. J Clin Psychiatry 39: 471-475, 1978.
15. Jepsen LV: Two cases of scleromyxedema. Acta Dermatovener (Stockholm) 60: 77-79, 1979.
16. Kaufman D, Truah AP, Roenigk HH: Scleromyxedema: systemic manifestations and cosmetic improvement from dermabrasion. Cutis 39: 321-324, 1987.
17. Kantor GR, Bergfeld WF, Katzin WE, et al.: Scleromyxedema associated with scleroderma renal disease and acute psoriasis. J Am Acad Dermatol 14: 879-888, 1986.
18. Reid TL, Spoto DV, Larrabee GJ, et al.: Monoclonal paraproteinemia with subacute encephalopathy, seizures, and scleromyxedema. Neurology 37: 1054-1057, 1987.
19. Milam CP, Cohen LE, Fenske NA, et al.: Scleromyxedema: therapeutic response to isotretinoin in three patients. J Am Acad Dermatol 19 469-477, 1988.
20. Godby A, Bergstresser PR, Chaker MB, et al.: Fatal scleromyxedema: report of a case and review of the literature. J Am Acad Dermatol 38: 289-294, 1998.
21. th ed (Champion RH, Burten JL, Burns DA, et al., eds), pp 2616-2618. Malden, Blackwell Science, 1998.
22. th ed, pp 188-190. Philadelphia, Saunders, 1990.
23. th ed (Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds), p 2188. New York, McGraw-Hill, 1993.